SCHEMBL23515363

SCHEMBL23515363

Oc1cccc(-c2cccnc2)c1Cc1c(O)cccc1-c1cccnc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 6/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ CYP3A4 P08684 2/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ MKNK1 Q9BUB5 2/20 0.43
▸ MKNK2 Q9HBH9 2/20 0.43
▸ CYP11B1 P15538 3/20 0.43
▸ CYP11B2 P19099 2/20 0.43
▸ KCNA5 P22460 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ ADRA2C P18825 1/20 0.42
▸ IKBKB O14920 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29625685 1.00 CYP2A6 (0.48) CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1
SCHEMBL29625661 0.87 FYN (0.46) ALDH1A1CYP3A4CYP1A2MKNK1MKNK2
SCHEMBL23515365 0.87 FYN (0.46) ALDH1A1CYP3A4CYP1A2MKNK1MKNK2
SCHEMBL23515203 0.81 PRKCI (0.42) ALDH1A1CYP3A4CYP11B1CYP11B2KDM4E
SCHEMBL18528875 0.81 CYP2A6 (0.52) CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1
SCHEMBL29625697 0.81 PRKCI (0.42) ALDH1A1CYP3A4CYP11B1CYP11B2KDM4E
SCHEMBL11206474 0.79 HSD17B10 (0.60) ALDH1A1CYP1A2HPGDHSD17B10CYP2C9
SCHEMBL30070521 0.79 ALDH1A1 (0.60) CYP2A6ALDH1A1CYP3A4CYP1A2CYP11B1
SCHEMBL1155160 0.79 ALDH1A1 (0.60) CYP2A6ALDH1A1CYP3A4CYP1A2CYP11B1
Hydrochloric Acid SCHEMBL21412299 0.77 ALDH1A1 (0.58) CYP2A6ALDH1A1CYP3A4CYP1A2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230015875-A1 Ion Channel Antagonists/Blockers and Uses Thereof SHANGHAI EAST HOSPITAL (CN) 2023-01-19 — — US disclosed
WO-2021114313-A1 ION CHANNEL ANTAGONISTS/BLOCKERS AND USES THEREOF SHANGHAI EAST HOSPITAL (CN) 2021-06-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230015875-A1 Ion Channel Antagonists/Blockers and Uses Thereof CACNA1F, CACNA1S, CACNA1D CYP2A6 522/4885ALDH1A1 1001/4885CYP3A4 538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback